Viewing Study NCT04003168


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2025-12-24 @ 5:56 PM
Study NCT ID: NCT04003168
Status: UNKNOWN
Last Update Posted: 2021-03-01
First Post: 2019-06-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma
Sponsor: Hrain Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module